Browse the evidence

Tirzepatide treatment significantly reduces the 10-year predicted risk of atherosclerotic cardiovascular disease (ASCVD) in adults with obesity or overweight without diabetes compared to placebo.

If you have obesity or overweight without diabetes, treatment with tirzepatide (a once-weekly injection) combined with lifestyle changes can significantly lower your calculated 10-year risk of heart disease compared to placebo. This benefit was observed across different baseline risk levels, suggesting it may be a valuable option for long-term cardiovascular health improvement in this population.

Certain diabetes medications (GLP-1 agonists and SGLT2 inhibitors) promote weight loss, whereas others (insulin, sulphonylureas, thiazolidinediones) cause weight gain, influencing the choice of therapy in obese patients.

When choosing diabetes medication, ask your doctor about its effect on your weight. Some drugs (like GLP-1 agonists and SGLT2 inhibitors) help you lose weight, while others (like insulin and sulphonylureas) may cause weight gain. If you have obesity, your doctor should prioritize medications that support weight loss.

SGLT-2 inhibitors reduce body weight (0.9-2.5 kg) and improve cardiovascular and renal outcomes in patients with diabesity by inducing glycosuria, making them a valuable class of medication for managing both metabolic and organ-specific risks.

SGLT-2 inhibitors (like Jardiance or Farxiga) are oral diabetes medications that also help with modest weight loss (1-2.5 kg) and protect your heart and kidneys. They work by removing excess sugar through urine. While this can increase the risk of yeast infections or UTIs, good hygiene and doctor guidance can manage this. They are particularly beneficial if you have heart or kidney risks associated with your diabetes.

Higher dietary glycemic load (GL) is associated with a significantly increased risk of coronary heart disease (CHD), with a relative risk of 1.44 per 65 g/d increase in GL among populations using valid dietary instruments.

To lower your risk of heart disease, pay attention to the glycemic load of your diet. This means choosing carbohydrates that have less impact on your blood sugar. The study suggests that for every 65 grams of glycemic load you consume daily, your risk of coronary heart disease increases by about 44% compared to lower intake, assuming you use accurate dietary tracking. Prioritize low-GL foods like vegetables, legumes, and whole grains over high-GL refined carbs.

Higher dietary glycemic index (GI) is associated with an increased risk of coronary heart disease, with a relative risk of 1.24 per 10 unit increase in GI on the glucose scale.

Choose carbohydrates with a lower Glycemic Index (GI) to support heart health. The study indicates that for every 10-unit increase in GI, your risk of coronary heart disease increases by about 24%. This means prioritizing foods that digest slowly and cause a smaller spike in blood sugar, such as legumes, whole grains, and non-starchy vegetables, over refined grains and sugary foods.

The risk of coronary heart disease from carbohydrate intake is significantly dependent on the Glycemic Index (GI) of the carbohydrates consumed, with higher GI amplifying the risk.

When consuming carbohydrates, their quality (Glycemic Index) significantly impacts your heart disease risk. The study shows that for every 98 grams of carbohydrates consumed, the risk of CHD increases by 66% for every 10-unit increase in the GI of those carbs. To protect your heart, choose carbohydrates with a lower GI, such as whole grains, legumes, and vegetables, and limit high-GI refined carbohydrates.

Intensive lifestyle intervention (ILI) aimed at weight loss reduces the incidence of obesity-related cancers by 16% in adults with type 2 diabetes, although the result was not statistically significant due to insufficient statistical power.

For individuals with type 2 diabetes and obesity, engaging in a structured weight loss program involving calorie restriction (1,200-1,800 kcal/day), moderate exercise (175 mins/week), and behavioral counseling can significantly lower the risk of developing obesity-related cancers. While the statistical evidence in this specific trial was borderline due to sample size, the consistent trend toward reduced risk suggests that maintaining a healthy weight is a critical cancer prevention strategy for this population.

GLP-1-based therapies achieve clinically meaningful weight loss (exceeding 10%) in type 2 diabetes and obesity by leveraging the gut-brain axis, specifically through the activation of satiety circuits in the brainstem (area postrema and nucleus of the solitary tract).

GLP-1 medications are currently the most effective pharmacological option for significant weight loss in people with obesity or type 2 diabetes. They work by mimicking a gut hormone that signals fullness to the brain. While they are injections, they are usually taken once a week. Common side effects like nausea are often temporary and can be managed by adjusting the dose. Consult a doctor to see if this treatment is appropriate for your specific health profile.

Fat adaptation (5 days high-fat diet) followed by carbohydrate restoration (1 day high-carb) increases resting AMPK activity and muscle triglyceride stores in trained humans, independent of muscle glycogen levels.

For trained athletes, a short period (5 days) of high-fat, low-carb dieting followed by one day of high-carb intake can increase resting AMPK activity and muscle fat stores. This strategy may enhance metabolic flexibility and fat oxidation during exercise without depleting glycogen, provided training volume is maintained.

Fat adaptation followed by carbohydrate restoration attenuates the exercise-induced rise in AMPK activity compared to a high-carbohydrate diet.

If you perform fat adaptation, your body may show a blunted AMPK response to subsequent exercise compared to when you are on a high-carb diet. This suggests a shift in how the muscle signals energy status during work.

Six months of body-weight-supported treadmill (BWST) training significantly improves blood glucose regulation and insulin sensitivity in individuals with incomplete spinal cord injury by increasing muscle GLUT-4 content, hexokinase activity, and glucose oxidation.

If you have an incomplete spinal cord injury, you can still improve your blood sugar control through exercise. Body-weight-supported treadmill training, where a harness helps support your weight while you walk, is effective. Doing this three times a week for six months can significantly lower your glucose and insulin levels after eating by helping your muscles process sugar better.

12 weeks of 500 mg/day Sensoril supplementation favors body mass distribution by reducing the increase in the android/gynoid ratio compared to placebo, without significantly altering total body fat or lean mass.

If you are looking to optimize body composition, 500 mg/day of Sensoril may help you maintain a healthier fat distribution (lower android/gynoid ratio) compared to placebo, even if it doesn't directly cause fat loss or muscle gain. This is a subtle benefit that supports long-term metabolic health.

High glycemic index (GI) carbohydrates induce metabolic damage primarily through rapid glucose absorption in the proximal small intestine, which stimulates GIP release from K cells, leading to lipogenesis, fatty liver, insulin resistance, and inflammation, whereas low GI carbohydrates bypass this mechanism.

To minimize metabolic damage from carbohydrates, prioritize foods with a low glycemic index (like isomaltulose, legumes, or whole grains) over high GI foods (like sucrose or white bread). This is because high GI foods are rapidly absorbed in the upper intestine, triggering GIP release which promotes fat storage, liver fat, and inflammation. Low GI foods are absorbed more slowly, bypassing the GIP-triggering K cells and instead stimulating beneficial GLP-1 release.

The hypertrophic benefit of creatine supplementation is modestly greater in younger adults compared to older adults, although the effect remains small in both groups.

Younger lifters may see a slightly better muscle growth boost from creatine than older lifters, but the difference is small. Older adults should still use creatine as it provides a small benefit, even if the magnitude is lower than in youth.

GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) provide a net health benefit for weight loss in non-diabetic adults with obesity, but only when the treatment goal is achieving ≥10% body weight loss; achieving 5% weight loss results in a net harm due to side effects.

If you are considering GLP-1 medications for weight loss without diabetes, understand that these drugs are most effective and 'worth it' if you aim to lose 10% or more of your body weight. Losing only 5% may actually result in a net negative health outcome due to side effects like nausea and vomiting. Ensure you are committed to lifestyle changes (diet and exercise) alongside the medication, and discuss your specific weight loss goals and tolerance for side effects with your doctor.

High-intensity interval training (HIT) in well-trained athletes improves metabolic control (increased fat oxidation, decreased lactate) without attenuating AMPK signaling or ACC phosphorylation in response to exercise.

If you are already a well-trained athlete, doing high-intensity intervals (8x5 minutes at 85% max effort) for just three weeks will significantly improve your body's ability to burn fat during exercise. Crucially, this training does not 'numb' your cellular signaling (AMPK); your muscles remain responsive to the stress, ensuring that your metabolic adaptations continue to occur.

Skeletal muscle hypertrophy from resistance training is driven primarily by chronic increases in translational capacity (ribosome biogenesis) and resting protein synthesis, rather than solely by acute post-exercise spikes in protein synthesis.

Focus on consistent resistance training over time to build more ribosomes in your muscles, which increases your baseline protein synthesis. Don't obsess over the exact timing of nutrients immediately post-workout, as total daily protein and long-term training consistency drive hypertrophy more than acute spikes.

Bariatric surgery improves periconception maternal health by normalizing hormonal axes and restoring menstrual cycle regularity, which leads to increased fertility, without increasing the risk of miscarriages or congenital malformations.

If you are considering bariatric surgery and plan to conceive, expect that your fertility will likely improve and menstrual cycles will become regular. However, you must commit to lifelong vitamin supplementation and regular monitoring to prevent deficiencies. Postpone pregnancy until weight loss stabilizes and vitamin levels are normalized to ensure optimal health for you and the fetus.

Saturated long-chain fatty acids (LCFAs) promote insulin resistance and ectopic fat deposition via diacylglycerol (DAG) and ceramide accumulation, whereas medium-chain fatty acids (MCFAs) and polyunsaturated fats do not produce these detrimental effects.

Limit saturated long-chain fatty acids (found in animal fats and dairy) and prioritize unsaturated fats (olive oil, nuts, fish) and medium-chain fats. The source of fat significantly impacts metabolic health.

Dietary fiber intake improves metabolic health by increasing short-chain fatty acid (SCFA) production, which activates G-protein-coupled receptors (GPCRs) to enhance insulin sensitivity, energy expenditure, and gut microbiome diversity.

Aim for 25-38g of fiber daily from whole plant sources. This supports gut health and metabolic function via SCFA production.

Restoring physiological signaling (e.g., via leptin administration) in weight-reduced individuals reverses metabolic adaptations (increased hunger, decreased energy expenditure) and promotes weight maintenance, whereas inducing weight loss alone is insufficient due to strong homeostatic defense of body fat.

If you have lost weight, expect your body to fight to regain it through increased hunger and slower metabolism. Simply losing weight is not enough; long-term success likely requires strategies that address these biological drivers, such as medical interventions that restore normal hormonal signaling, rather than relying solely on willpower.

Intensive glucose-lowering strategies in type 2 diabetes significantly reduce the risk of non-fatal myocardial infarction and microvascular complications (retinopathy, nephropathy) compared to standard therapy, but do not significantly reduce major adverse cardiovascular events (MACE) or all-cause mortality.

For people with Type 2 Diabetes, aiming for very low blood sugar levels (intensive control) is beneficial for protecting your eyes and kidneys, and may slightly reduce the risk of non-fatal heart attacks. However, it does not significantly reduce the risk of major heart events, stroke, or death compared to standard control. Therefore, intensive glucose lowering should be combined with aggressive management of blood pressure and lipids, rather than being the sole focus for heart health.

Bariatric surgery (specifically LRYGB, LSG, or LAGB) significantly improves metabolic syndrome, insulin resistance, and reproductive function (menstrual regularity, ovulation) in PCOS patients compared to lifestyle modifications alone.

If you have PCOS and obesity, bariatric surgery is a highly effective medical intervention that can reverse metabolic syndrome and restore fertility more effectively than diet and exercise alone. It reduces risks of diabetes, hypertension, and pregnancy complications. While surgery carries risks, they are lower than before, and pregnancy outcomes are generally safe and improved compared to pre-surgery states. Consult a specialist to determine if you are a candidate.

Resistance training-induced muscle hypertrophy is regulated by a core set of 141 genes, including specific regulation of mRNA 3' and 5' untranslated regions (UTRs), which directly modulate protein synthesis and lean mass gains.

To maximize muscle growth, focus on consistent resistance training. The research suggests that individual genetic responses (specifically how your body regulates gene expression via UTRs) dictate your growth potential. While you cannot change your genes, understanding that 'responders' and 'non-responders' exist at a molecular level may help manage expectations. Consistency is key, as the molecular machinery adapts to the loading stimulus.